2024 Q4 Form 10-Q Financial Statement
#000109690624002132 Filed on November 14, 2024
Income Statement
Concept | 2024 Q4 | 2024 Q3 |
---|---|---|
Revenue | $0.00 | |
YoY Change | ||
Cost Of Revenue | $0.00 | |
YoY Change | -100.0% | |
Gross Profit | $0.00 | |
YoY Change | -100.0% | |
Gross Profit Margin | ||
Selling, General & Admin | ||
YoY Change | ||
% of Gross Profit | ||
Research & Development | ||
YoY Change | ||
% of Gross Profit | ||
Depreciation & Amortization | ||
YoY Change | ||
% of Gross Profit | ||
Operating Expenses | $46.06K | |
YoY Change | -11.43% | |
Operating Profit | -$46.06K | |
YoY Change | -14.5% | |
Interest Expense | ||
YoY Change | ||
% of Operating Profit | ||
Other Income/Expense, Net | $37.43K | |
YoY Change | 14993.15% | |
Pretax Income | ||
YoY Change | ||
Income Tax | ||
% Of Pretax Income | ||
Net Earnings | -$90.16K | |
YoY Change | 68.12% | |
Net Earnings / Revenue | ||
Basic Earnings Per Share | ||
Diluted Earnings Per Share | ||
COMMON SHARES | ||
Basic Shares Outstanding | 30.00M shares | 26.93M shares |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2024 Q4 | 2024 Q3 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | ||
YoY Change | ||
Cash & Equivalents | $34.29K | |
Short-Term Investments | ||
Other Short-Term Assets | ||
YoY Change | ||
Inventory | $0.00 | |
Prepaid Expenses | ||
Receivables | $6.680K | |
Other Receivables | ||
Total Short-Term Assets | $381.1K | |
YoY Change | 126.09% | |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | ||
YoY Change | ||
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | ||
YoY Change | ||
Total Long-Term Assets | $0.00 | |
YoY Change | -100.0% | |
TOTAL ASSETS | ||
Total Short-Term Assets | $381.1K | |
Total Long-Term Assets | $0.00 | |
Total Assets | $381.1K | |
YoY Change | -46.43% | |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $153.8K | |
YoY Change | 171.06% | |
Accrued Expenses | ||
YoY Change | ||
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | ||
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $160.8K | |
YoY Change | 133.46% | |
LONG-TERM LIABILITIES | ||
Long-Term Debt | ||
YoY Change | ||
Other Long-Term Liabilities | ||
YoY Change | ||
Total Long-Term Liabilities | $568.9K | |
YoY Change | -66.47% | |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $160.8K | |
Total Long-Term Liabilities | $568.9K | |
Total Liabilities | $729.7K | |
YoY Change | -58.67% | |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$2.159M | |
YoY Change | 12.05% | |
Common Stock | $3.000K | |
YoY Change | 14.5% | |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | -$1.150M | |
YoY Change | ||
Total Liabilities & Shareholders Equity | $381.1K | |
YoY Change | -46.43% |
Cashflow Statement
Concept | 2024 Q4 | 2024 Q3 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$90.16K | |
YoY Change | 68.12% | |
Depreciation, Depletion And Amortization | ||
YoY Change | ||
Cash From Operating Activities | ||
YoY Change | ||
INVESTING ACTIVITIES | ||
Capital Expenditures | ||
YoY Change | ||
Acquisitions | ||
YoY Change | ||
Other Investing Activities | ||
YoY Change | ||
Cash From Investing Activities | ||
YoY Change | ||
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | ||
YoY Change | ||
NET CHANGE | ||
Cash From Operating Activities | ||
Cash From Investing Activities | ||
Cash From Financing Activities | ||
Net Change In Cash | ||
YoY Change | ||
FREE CASH FLOW | ||
Cash From Operating Activities | ||
Capital Expenditures | ||
Free Cash Flow | ||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2024 | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001543652 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2024-09-30 | ||
dei |
Entity File Number
EntityFileNumber
|
000-54868 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
Free Flow USA Inc. | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
45-3838831 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
9243 John F. Kennedy Blvd. | ||
dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Ste. 104 | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
North Bergen | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
NJ | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
07047 | ||
dei |
Entity Address Address Description
EntityAddressAddressDescription
|
Address of Principal Executive Offices | ||
dei |
City Area Code
CityAreaCode
|
703 | ||
dei |
Local Phone Number
LocalPhoneNumber
|
789-3344 | ||
dei |
Phone Fax Number Description
PhoneFaxNumberDescription
|
Registrant’s Telephone Number | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
CY2024Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
30000000 | shares |
CY2024Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
34289 | usd |
CY2023Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
39521 | usd |
CY2024Q3 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
6680 | usd |
CY2023Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
95440 | usd |
CY2024Q3 | fil |
Refund Due From Irs Ertc
RefundDueFromIrsErtc
|
32730 | usd |
CY2023Q4 | fil |
Refund Due From Irs Ertc
RefundDueFromIrsErtc
|
32730 | usd |
CY2024Q3 | us-gaap |
Notes Receivable Net
NotesReceivableNet
|
300000 | usd |
CY2023Q4 | us-gaap |
Notes Receivable Net
NotesReceivableNet
|
0 | usd |
CY2024Q3 | fil |
Rounding Off Decimal Error
RoundingOffDecimalError
|
0 | usd |
CY2023Q4 | fil |
Rounding Off Decimal Error
RoundingOffDecimalError
|
-2 | usd |
CY2024Q3 | fil |
Intra Company
IntraCompany
|
7423 | usd |
CY2023Q4 | fil |
Intra Company
IntraCompany
|
0 | usd |
CY2024Q3 | us-gaap |
Inventory Net
InventoryNet
|
0 | usd |
CY2023Q4 | us-gaap |
Inventory Net
InventoryNet
|
4800 | usd |
CY2024Q3 | us-gaap |
Assets Current
AssetsCurrent
|
381121 | usd |
CY2023Q4 | us-gaap |
Assets Current
AssetsCurrent
|
172489 | usd |
CY2024Q3 | us-gaap |
Land Improvements
LandImprovements
|
0 | usd |
CY2023Q4 | us-gaap |
Land Improvements
LandImprovements
|
772413 | usd |
CY2024Q3 | fil |
Accumulated Depreciation Fixed Assets
AccumulatedDepreciationFixedAssets
|
0 | usd |
CY2023Q4 | fil |
Accumulated Depreciation Fixed Assets
AccumulatedDepreciationFixedAssets
|
283731 | usd |
CY2024Q3 | us-gaap |
Land And Land Improvements
LandAndLandImprovements
|
0 | usd |
CY2023Q4 | us-gaap |
Land And Land Improvements
LandAndLandImprovements
|
488682 | usd |
CY2024Q3 | fil |
Delivery Trucks At Cost
DeliveryTrucksAtCost
|
0 | usd |
CY2023Q4 | fil |
Delivery Trucks At Cost
DeliveryTrucksAtCost
|
2500 | usd |
CY2024Q3 | fil |
Accumulated Depreciation In Other Assets
AccumulatedDepreciationInOtherAssets
|
0 | usd |
CY2023Q4 | fil |
Accumulated Depreciation In Other Assets
AccumulatedDepreciationInOtherAssets
|
-2500 | usd |
CY2024Q3 | us-gaap |
Furniture And Fixtures Gross
FurnitureAndFixturesGross
|
0 | usd |
CY2023Q4 | us-gaap |
Furniture And Fixtures Gross
FurnitureAndFixturesGross
|
11697 | usd |
CY2024Q3 | us-gaap |
Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
|
0 | usd |
CY2023Q4 | us-gaap |
Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
|
31712 | usd |
CY2024Q3 | fil |
Accumulated Depreciation Of Furniture And Equipment
AccumulatedDepreciationOfFurnitureAndEquipment
|
0 | usd |
CY2023Q4 | fil |
Accumulated Depreciation Of Furniture And Equipment
AccumulatedDepreciationOfFurnitureAndEquipment
|
-31712 | usd |
CY2024Q3 | us-gaap |
Other Assets
OtherAssets
|
0 | usd |
CY2023Q4 | us-gaap |
Other Assets
OtherAssets
|
11697 | usd |
CY2024Q3 | us-gaap |
Assets
Assets
|
381121 | usd |
CY2023Q4 | us-gaap |
Assets
Assets
|
672868 | usd |
CY2024Q3 | us-gaap |
Accounts Payable Trade Current
AccountsPayableTradeCurrent
|
6990 | usd |
CY2023Q4 | us-gaap |
Accounts Payable Trade Current
AccountsPayableTradeCurrent
|
138669 | usd |
CY2024Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
153820 | usd |
CY2024Q3 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
0 | usd |
CY2023Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
2500 | usd |
CY2024Q3 | fil |
Notes Payable Related Parties
NotesPayableRelatedParties
|
0 | usd |
CY2023Q4 | fil |
Notes Payable Related Parties
NotesPayableRelatedParties
|
9634 | usd |
CY2024Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
160810 | usd |
CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
150803 | usd |
CY2024Q3 | us-gaap |
Long Term Loans Payable
LongTermLoansPayable
|
499647 | usd |
CY2023Q4 | us-gaap |
Long Term Loans Payable
LongTermLoansPayable
|
499900 | usd |
CY2024Q3 | fil |
Paypal Advance
PaypalAdvance
|
0 | usd |
CY2023Q4 | fil |
Paypal Advance
PaypalAdvance
|
29517 | usd |
CY2024Q3 | us-gaap |
Line Of Credit Facility Fair Value Of Amount Outstanding
LineOfCreditFacilityFairValueOfAmountOutstanding
|
69276 | usd |
CY2023Q4 | us-gaap |
Line Of Credit Facility Fair Value Of Amount Outstanding
LineOfCreditFacilityFairValueOfAmountOutstanding
|
1207723 | usd |
CY2024Q3 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
568923 | usd |
CY2023Q4 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
1737140 | usd |
CY2024Q3 | us-gaap |
Liabilities
Liabilities
|
729733 | usd |
CY2023Q4 | us-gaap |
Liabilities
Liabilities
|
1887943 | usd |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2024Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2024Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2024Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
30000000 | shares |
CY2024Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
30000000 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
25876900 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
25876900 | shares |
CY2024Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
3000 | usd |
CY2023Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
2622 | usd |
CY2024Q3 | fil |
Forfeited Shares Account
ForfeitedSharesAccount
|
138 | usd |
CY2023Q4 | fil |
Forfeited Shares Account
ForfeitedSharesAccount
|
0 | usd |
CY2024Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
349824 | usd |
CY2023Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
140033 | usd |
CY2024Q3 | us-gaap |
Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
|
75000 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
|
0 | usd |
CY2023Q4 | us-gaap |
Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
|
0 | usd |
CY2024Q3 | fil |
Income For The Period
IncomeForThePeriod
|
731155 | usd |
CY2023Q4 | fil |
Income For The Period
IncomeForThePeriod
|
-232156 | usd |
CY2024Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-2158666 | usd |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-1926509 | usd |
CY2024Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-1149547 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-2016010 | usd |
CY2024Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
381121 | usd |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
672868 | usd |
us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
6123 | usd | |
us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
4032 | usd | |
CY2024Q3 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
0 | usd |
CY2023Q3 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
0 | usd |
us-gaap |
Revenues
Revenues
|
6123 | usd | |
us-gaap |
Revenues
Revenues
|
4032 | usd | |
CY2024Q3 | us-gaap |
Revenues
Revenues
|
0 | usd |
CY2023Q3 | us-gaap |
Revenues
Revenues
|
0 | usd |
us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
3785 | usd | |
us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
15571 | usd | |
CY2024Q3 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
0 | usd |
CY2023Q3 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
1868 | usd |
us-gaap |
Gross Profit
GrossProfit
|
2339 | usd | |
us-gaap |
Gross Profit
GrossProfit
|
-11539 | usd | |
CY2024Q3 | us-gaap |
Gross Profit
GrossProfit
|
0 | usd |
CY2023Q3 | us-gaap |
Gross Profit
GrossProfit
|
-1868 | usd |
us-gaap |
Administrative Fees Expense
AdministrativeFeesExpense
|
32350 | usd | |
us-gaap |
Administrative Fees Expense
AdministrativeFeesExpense
|
37449 | usd | |
CY2024Q3 | us-gaap |
Administrative Fees Expense
AdministrativeFeesExpense
|
8282 | usd |
CY2023Q3 | us-gaap |
Administrative Fees Expense
AdministrativeFeesExpense
|
11372 | usd |
us-gaap |
Professional Fees
ProfessionalFees
|
154015 | usd | |
us-gaap |
Professional Fees
ProfessionalFees
|
20179 | usd | |
CY2024Q3 | us-gaap |
Professional Fees
ProfessionalFees
|
25508 | usd |
CY2023Q3 | us-gaap |
Professional Fees
ProfessionalFees
|
5467 | usd |
us-gaap |
Selling Expense
SellingExpense
|
14039 | usd | |
us-gaap |
Selling Expense
SellingExpense
|
5879 | usd | |
CY2024Q3 | us-gaap |
Selling Expense
SellingExpense
|
11931 | usd |
CY2023Q3 | us-gaap |
Selling Expense
SellingExpense
|
5556 | usd |
fil |
Financial Expenses
FinancialExpenses
|
228537 | usd | |
fil |
Financial Expenses
FinancialExpenses
|
30314 | usd | |
CY2024Q3 | fil |
Financial Expenses
FinancialExpenses
|
341 | usd |
CY2023Q3 | fil |
Financial Expenses
FinancialExpenses
|
29611 | usd |
us-gaap |
Operating Expenses
OperatingExpenses
|
428941 | usd | |
us-gaap |
Operating Expenses
OperatingExpenses
|
93821 | usd | |
CY2024Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
46062 | usd |
CY2023Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
52006 | usd |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-426602 | usd | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-105360 | usd | |
CY2024Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-46062 | usd |
CY2023Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-53874 | usd |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
39664 | usd | |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
34295 | usd | |
CY2024Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
37431 | usd |
CY2023Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
248 | usd |
us-gaap |
Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
|
1199622 | usd | |
us-gaap |
Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
|
0 | usd | |
CY2024Q3 | us-gaap |
Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
|
0 | usd |
CY2023Q3 | us-gaap |
Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
|
0 | usd |
us-gaap |
Other Income
OtherIncome
|
-81527 | usd | |
us-gaap |
Other Income
OtherIncome
|
0 | usd | |
CY2024Q3 | us-gaap |
Other Income
OtherIncome
|
-81527 | usd |
CY2023Q3 | us-gaap |
Other Income
OtherIncome
|
0 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
731155 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-71066 | usd | |
CY2024Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-90158 | usd |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-53626 | usd |
fil |
Basis Income Loss Per Share
BasisIncomeLossPerShare
|
0.024 | ||
fil |
Basis Income Loss Per Share
BasisIncomeLossPerShare
|
-0.003 | ||
CY2024Q3 | fil |
Basis Income Loss Per Share
BasisIncomeLossPerShare
|
-0.003 | |
CY2023Q3 | fil |
Basis Income Loss Per Share
BasisIncomeLossPerShare
|
-0.002 | |
fil |
Weighted Average Number Of Common Shares Outstanding
WeightedAverageNumberOfCommonSharesOutstanding
|
30000000 | shares | |
fil |
Weighted Average Number Of Common Shares Outstanding
WeightedAverageNumberOfCommonSharesOutstanding
|
25876900 | shares | |
CY2024Q3 | fil |
Weighted Average Number Of Common Shares Outstanding
WeightedAverageNumberOfCommonSharesOutstanding
|
30000000 | shares |
CY2023Q3 | fil |
Weighted Average Number Of Common Shares Outstanding
WeightedAverageNumberOfCommonSharesOutstanding
|
25876900 | shares |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-2016009 | usd |
CY2024Q1 | fil |
Additionalsubscription
Additionalsubscription
|
10000 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
836018 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1169991 | usd |
CY2024Q2 | us-gaap |
Stock Issued1
StockIssued1
|
0 | usd |
CY2024Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-14705 | usd |
CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1184696 | usd |
CY2024Q3 | us-gaap |
Stock Issued1
StockIssued1
|
511 | usd |
CY2024Q3 | fil |
Subscription Received
SubscriptionReceived
|
124797 | usd |
CY2024Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-90158 | usd |
CY2024Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1149547 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1794855 | usd |
CY2023Q1 | us-gaap |
Stock Granted During Period Value Sharebased Compensation Forfeited
StockGrantedDuringPeriodValueSharebasedCompensationForfeited
|
0 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-19429 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1814284 | usd |
CY2023Q2 | us-gaap |
Stock Issued1
StockIssued1
|
11000 | usd |
CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
1989 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1801295 | usd |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-53626 | usd |
CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1854921 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
731155 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-71066 | usd | |
us-gaap |
Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
|
1211318 | usd | |
us-gaap |
Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
|
0 | usd | |
fil |
Pnc Clover Note Written Off
PncCloverNoteWrittenOff
|
0 | usd | |
fil |
Pnc Clover Note Written Off
PncCloverNoteWrittenOff
|
-10402 | usd | |
fil |
Paypal Loan Written Off
PaypalLoanWrittenOff
|
-29518 | usd | |
fil |
Paypal Loan Written Off
PaypalLoanWrittenOff
|
0 | usd | |
fil |
Inventory Written Off
InventoryWrittenOff
|
0 | usd | |
fil |
Inventory Written Off
InventoryWrittenOff
|
890 | usd | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-88760 | usd | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-50 | usd | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-4800 | usd | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
0 | usd | |
us-gaap |
Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
|
0 | usd | |
us-gaap |
Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
|
11182 | usd | |
us-gaap |
Increase Decrease In Notes Receivables
IncreaseDecreaseInNotesReceivables
|
300000 | usd | |
us-gaap |
Increase Decrease In Notes Receivables
IncreaseDecreaseInNotesReceivables
|
0 | usd | |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
22141 | usd | |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
55100 | usd | |
us-gaap |
Increase Decrease In Notes Payable Current
IncreaseDecreaseInNotesPayableCurrent
|
-2500 | usd | |
us-gaap |
Increase Decrease In Notes Payable Current
IncreaseDecreaseInNotesPayableCurrent
|
0 | usd | |
fil |
Increase Decrease In Intercompany Payables
IncreaseDecreaseInIntercompanyPayables
|
-17057 | usd | |
fil |
Increase Decrease In Intercompany Payables
IncreaseDecreaseInIntercompanyPayables
|
0 | usd | |
fil |
Payment Against Improvement In Progress
PaymentAgainstImprovementInProgress
|
11697 | usd | |
fil |
Payment Against Improvement In Progress
PaymentAgainstImprovementInProgress
|
0 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-701840 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-14246 | usd | |
fil |
Payment For Improvement In Progress
PaymentForImprovementInProgress
|
0 | usd | |
fil |
Payment For Improvement In Progress
PaymentForImprovementInProgress
|
-1000 | usd | |
us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
1700000 | usd | |
us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
0 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
1700000 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-1000 | usd | |
us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
0 | usd | |
us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
2500 | usd | |
fil |
Proceeds From Pay Pal Advance
ProceedsFromPayPalAdvance
|
0 | usd | |
fil |
Proceeds From Pay Pal Advance
ProceedsFromPayPalAdvance
|
-4011 | usd | |
fil |
Repayment Of Eidl Loan
RepaymentOfEidlLoan
|
253 | usd | |
fil |
Repayment Of Eidl Loan
RepaymentOfEidlLoan
|
0 | usd | |
fil |
Incredible Bank Loan Express Loan
IncredibleBankLoanExpressLoan
|
299212 | usd | |
fil |
Incredible Bank Loan Express Loan
IncredibleBankLoanExpressLoan
|
0 | usd | |
fil |
Incredible Bank Loan Plp Loan
IncredibleBankLoanPlpLoan
|
839235 | usd | |
fil |
Incredible Bank Loan Plp Loan
IncredibleBankLoanPlpLoan
|
4000 | usd | |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
-307 | usd | |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | usd | |
fil |
Subscription Share Capital
SubscriptionShareCapital
|
125000 | usd | |
fil |
Subscription Share Capital
SubscriptionShareCapital
|
0 | usd | |
fil |
Proceeds From Subscription Money
ProceedsFromSubscriptionMoney
|
10000 | usd | |
fil |
Proceeds From Subscription Money
ProceedsFromSubscriptionMoney
|
11000 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-1003393 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
5489 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-5232 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-9757 | usd | |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
39521 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
17274 | usd |
CY2024Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
34289 | usd |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
7517 | usd |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="font:10pt stHtmlOvrFontNm;margin:0"><span style="border-bottom:1px solid #000000"><b>Use</b><b> </b><b>of</b><b> </b><b>Estimates</b></span></p> <p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:justify"> </p> <p style="font:10pt stHtmlOvrFontNm;margin:0;text-align:justify">In preparing the consolidated financial statements in conformity with U.S GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions made by management include but are not limited to, revenue recognition, the allowance for bad debts, income taxes, and unrecognized tax benefits. Actual results could differ from those estimates.</p> | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
1052419 | usd | |
CY2024Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2024Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2019Q2 | fil |
Proceeds From Issuance Of Restricted Shares
ProceedsFromIssuanceOfRestrictedShares
|
14490 | usd |
CY2019Q2 | us-gaap |
Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
|
21000 | shares |
CY2024Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
30000000 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
25876900 | shares |
fil |
Description Of Private Placement Memorandum
DescriptionOfPrivatePlacementMemorandum
|
On August 17, 2020 the Company completed its Private Placement Memorandum (PPM) to raise $19.5 million with no minimum, against issuance of 15,000,000 Series “D” shares at a price of $1.30 per share. The PPM was withdrawn while the allocation of 15 million shares of Series “D” is still valid. |